Inside the Bottle brings you the latest supplement industry news in this monthly roundup
If you are having trouble reading this email, read the online version | | | Consumers want dietary supplements that work for them and they’re willing to pay more for those that are clinically proven. In this new video from Inside the Bottle, Radicle Science Co-Founder and Executive Chair Pelin Thorogood addresses the path to gaining and keeping consumer trust –– explaining that properly designed trials and transparent communication and access to efficacy data, for retailers and consumers alike, are critical to supporting industry quality and consumer trust. | | NBJ releases new Condition Specific Report — research
Arm yourself with the latest data and analysis of the top 22 conditions driving supplement sales — and the ingredients that target them — with the brand new NBJ Condition Specific Report. Then, explore innovations, opportunities and challenges in the exploding mushroom market in the new NBJ Mushroom Market Report, including a special psilocybin feature.
| |
|---|
|
Sen. Durbin reintroduces Dietary Supplement Listing Act — article
Durbin reintroduced a 2024 version of the bill he failed to push through Congress in 2022, claiming FDA cannot effectively regulate or police the market if it does not know the extent of all supplements sold in the U.S. Learn what the bill requires of companies and keep up with industry’s response on Natural Products Insider. | | On July 26, FDA disclosed recently receiving an adverse event report of an individual who died after using OPMS Black Liquid Kratom. As result, FDA issued a consumer advisory warning consumers not to use the product. It reinforced its position that the botanical cannot be lawfully marketed as a dietary supplement. Read more here. |
|---|
| |
|
|
| | | | Inside the Bottle unites companies from across the supplement supply chain to advocate for a transparent, collaborative supplement industry that supports consumer health empowerment. #InsidetheBottle
|
|---|
|
| |
|
|
|
|
This email was sent to you by the Informa Markets Division of Informa PLC (Privacy Policy).
Informa PLC's registered office is 5 Howick Place, London SW1P 1WG.
Registered in England and Wales. Number 8860726.
If you do not wish to receive further information from us, please click here.
Alternatively, to contact our data services team to have your details or preferences updated please email imdatateam@informa.com. 